Skip to main content

Saffron™ Fixation System

The Saffron™ Fixation System (Coloplast Corp., Minneapolis, MN) is a contemporary anchor-based device (ABD) for sacrospinous ligament (SSL) fixation in apical pelvic-organ-prolapse repair. Engineered to enable precise anchor placement in the SSL with the goal of reducing neurovascular injury risk, the system aims to facilitate a durable, fast, complication-minimizing apical-suspension procedure. Like the Anchorsure, it delivers a permanent biocompatible anchor into the ligament rather than capturing a suture across it.[1]

Design

  • Two-piece system:
    1. Saffron tool — curved, ergonomic reusable handle; reprocessed between cases
    2. Saffron anchors — biocompatible, single-use, permanently implanted; sold in boxes of 12
  • Narrow distal tip for clean entry into the dissection plane and accurate anchor placement
  • Curved body matching the approach angle to the sacrospinous ligament
  • Intuitive ergonomics for single-handed operation

Evidence — Cadaveric Validation Only

The Saffron has been validated in a single cadaveric observational study (van Raalte 2023, Int Urogynecol J). No clinical (in vivo) studies have been published.[1]

EndpointResult
Anchor placement accuracy19/20 anchors (95%) correctly placed, by independent non-implanting-surgeon assessment
Neurovascular clearanceAll anchors > 10 mm from surrounding nerves and vessels
Pull-out force (holding strength)17.9 ± 5.6 N mean
Study design4 human cadavers, 3 implanters; pull-out force in 3 cadavers, anatomic distance measurements in 1

The authors explicitly note that "future clinical studies are needed to explore if the theoretical advantages of this device translate to improved clinical outcomes in comparison with available suturing and anchoring devices."[1]

Positioning in the SSLF Landscape

The Saffron joins the Anchorsure as a contemporary anchor-based alternative to the dominant suture-capturing devices (Capio, i-Stitch, Endostitch) and the legacy suture-passers (Miya hook, Deschamps ligature carrier). The anchor-based concept addresses the same clinical pain point — characteristic gluteal / buttock pain after traditional SSLF — by embedding fixation within ligament substance rather than encircling or compressing it.

SSLF Device Landscape — Level of Evidence

DeviceTypeManufacturerLevel of Evidence
Capio / Capio SLIMSuture-capturingBoston ScientificMultiple clinical studies + systematic reviews
AnchorsureAnchor-basedNeomedicRCTs (Plair 2022)[2], case-control (Evangelopoulos 2024)[3], large retrospective series
SaffronAnchor-basedColoplastCadaveric study only (van Raalte 2023)[1]
EnPlaceSuture-passingNeomedicClinical cohort studies (Neuman 2025)[4]
Deschamps ligature carrierSuture-passingVariousExtensive long-term clinical data

The Amiri 2024 meta-analysis frames the broader pattern across SSLF devices: overall complication rates are low across all devices, but specific profiles diverge — suture-capturing devices tend to have higher nerve-injury rates, while anchor-based devices may have slightly higher reoperation rates.[5]

Clinical Status

The Saffron's promising preclinical metrics — 95% accuracy, > 10 mm neurovascular clearance, 17.9 N pull-out force — have not yet been validated in human clinical use. Until clinical data emerge, the Capio (suture-capturing, deepest evidence base) and Anchorsure (anchor-based, RCT + large retrospective series) remain the SSLF devices with the strongest evidence at the bedside.

Use

  • Apical POP repair — vaginal vault suspension after hysterectomy
  • Uterovaginal prolapse fixation
  • Native-tissue (mesh-free) apical suspension

See also: Anchorsure System, Capio Suture Capturing Device, i-Stitch, Endostitch, Miya Hook, Deschamps Ligature Carrier.


References

1. van Raalte H, Bhatia N, Mangel J, Ryckebusch H, Roovers JP. "A novel anchoring system for pelvic organ prolapse repair: an observational study." Int Urogynecol J. 2023;34(7):1593–1598. doi:10.1007/s00192-022-05444-7

2. Plair A, Smith W, Hines K, et al. "Gluteal and posterior thigh pain from a suture compared with an anchor-based device in patients undergoing sacrospinous ligament fixation: a randomized controlled trial." Obstet Gynecol. 2022;139(1):97–106. doi:10.1097/AOG.0000000000004629

3. Evangelopoulos N, Delacroix C, Abdirahman S, de Tayrac R. "Safety of an anchor-based device for sacrospinous ligament fixation: a pilot case-control study." Eur J Obstet Gynecol Reprod Biol. 2024;299:105–109. doi:10.1016/j.ejogrb.2024.06.012

4. Neuman J, Groutz A, Neuman M, Gold RS. "Is transvaginal minimally invasive sacrospinous ligament fixation a safe and effective surgical approach for treating recurrent apical pelvic organ prolapse?" J Clin Med. 2025;14(15):5235. doi:10.3390/jcm14155235

5. Amiri E, Bastani P, Mallah F, Mostafaei H, Salehi-Pourmehr H. "Comparison of the complications rate of different suture-passing techniques at the time of sacrospinous ligament fixation: a systematic review and meta-analysis." Arch Gynecol Obstet. 2024;310(6):2791–2809. doi:10.1007/s00404-024-07788-5